Skip to main content
. 2010 Jun 7;31(19):2338–2350. doi: 10.1093/eurheartj/ehq165

Funding of the included databases

Centre Origin of funding
Rotterdam (The Netherlands)
Cambridge/Cardiff (UK) British Heart Foundation, National Institute for Health Research
HEGP, Paris (France) Agence nationale de la recherche (ANR), INSERM, Fondation de Recherche en Hypertension
Copenhagen (Denmark) Danish Heart Foundation (grant 01-2-9-9A-22914), the Lundbeck Fonden (grant R32-A2740).
Ghent (Belgium) The Asklepios study was funded by FWO research grant G042703
Athens (Greece)
Nancy (France) Agence nationale de la recherche (ANR), INSERM, Fondation de Recherche en Hypertension
Amsterdam/Maastricht (The Netherlands) Hoorn study: The Netherlands Heart Foundation (Grant no. 98154) Amsterdam Growth and Health Longitudinal Study (AGAHLS): Dutch Prevention Fund (ZON), and The Netherlands Heart Foundation (post-doc grant no. 2006T050—Dr I. Ferreira)
Paris XIII (France) INSERM
Fleury-Mérogis (France) Agence nationale de la recherche (ANR), INSERM, Fondation de Recherche en Hypertension
Manchester (UK) British Heart Foundation
Brescia (Italy)
Plzen (Czech Republic) 7th Framework Programme of the EU, grant agreement number 201550